Cabral M, Martín-Venegas R, Moreno JJ. Differential cell growth/apoptosis behavior of 13-hydroxyoctadecadienoic acid enantiomers in a colorectal cancer cell line. Am J Physiol Gastrointest Liver Physiol 307: G664 -G671, 2014. First published July 17, 2014 doi:10.1152/ajpgi.00064.2014 and lipoxygenases (LOXs) are important enzymes that metabolize arachidonic and linoleic acids. Various metabolites generated by the arachidonic acid cascade regulate cell proliferation, apoptosis, differentiation, and senescence. Hydroxyoctadecadienoic acids (HODEs) are synthesized from linoleic acid, giving two enantiomeric forms for each metabolite. The aim was to investigate the effect of 13-HODE enantiomers on nondifferentiated Caco-2 cell growth/apoptosis. Our results indicate that 13(S)-HODE decreases cell growth and DNA synthesis of nondifferentiated Caco-2 cells cultured with 10% fetal bovine serum (FBS). Moreover, 13(S)-HODE showed an apoptotic effect that was reduced in the presence of a specific peroxisome proliferator-activated receptor-␥ (PPAR␥) antagonist. In addition, we observed that 13(S)-HODE but not 13(R)-HODE is a ligand to PPAR␥, confirming the implication of this nuclear receptor in 13(S)-HODE actions. In contrast, 13(R)-HODE increases cell growth and DNA synthesis in the absence of FBS. 13(R)-HODE interaction with BLT receptors activates ERK and CREB signaling pathways, as well as PGE2 synthesis. These results suggest that the proliferative effect of 13(R)-HODE could be due, at least in part, to COX pathway activation. Thus both enantiomers use different receptors and have contrary effects. We also found these differential effects of 9-HODE enantiomers on cell growth/ apoptosis. Therefore, the balance between (R)-HODEs and (S)-HODEs in the intestinal epithelium could be important to its cell growth/apoptosis homeostasis.
THE ARACHIDONIC ACID (AA) cascade is responsible for the generation of a wide variety of bioactive metabolites involved in many different pathological states, including inflammation and cancer (1, 18) . Thus these metabolites regulate cell proliferation, apoptosis, differentiation, and senescence. Indeed, the functional relationship between polyunsaturated fatty acid metabolism, inflammation, and carcinogenesis has been examined in numerous molecular studies, revealing possible new targets for chemoprevention and/or treatment of a number of cancers (9) .
Cyclooxygenases (COXs) and lipoxygenases (LOXs) are two important enzymatic groups that metabolize polyunsaturated fatty acids. COX has two isoforms (COX-1 and COX-2) and produces prostaglandins (PGs) and thromboxanes. LOXs constitute a family of dioxygenases that insert molecular oxygen into free and/or esterified polyunsaturated fatty acids with regional specificity and are designated 5-, 8-, 12-and 15-LOX, accordingly (12, 13) . Thus these enzymes metabolize AA to the biologically active metabolites hydroperoxyeicosatetraenoic acids, which on reduction form corresponding hydroeicosatetranoic acids (HETEs), while the metabolism of linoleic acid preferentially results in the formation of hydroxyoctadecadienoic acids (HODEs). Therefore, HETEs are the main AA metabolites formed by mammalian LOXs, and 9-and 13-HODE are the principal reaction products of linoleic acid oxygenation by 12-LOX and 15-LOX, respectively. 15-LOX can be subclassified, according to the specificity of tissue distribution and enzymatic characteristics, into 15-LOX-1 and 15-LOX-2. While 15-LOX-2 metabolizes AA but not linoleic acid, 15-LOX-1 converts linoleic acid and AA to their metabolites, 13-HODE and 15-HETE, respectively, and is expressed preferentially in reticulocytes, eosinophils, macrophages, tracheobronchial epithelial cells, skin, and colon (21, 29) . Interestingly, 15-LOX-1 prefers linoleic acid over AA as substrate and produces 13-HODE in excess when both fatty acids are available. Moreover, we must consider that there are two stereoisomers of 13-HODE, 13-sinister-HODE [13(S)-HODE] and 13-rectus-HODE [13(R)-HODE]. While 13(S)-HODE is only produced in the metabolism of linoleic acid by 15-LOX-1 (38, 44), 13(R)-HODE can be generated by several LOXs and COXs, as well as by autooxidation processes (3, 4, 5, 36, 43) .
HETEs and HODES are known to modulate inflammation and may be important factors in carcinogenesis (32, 38, 44) . In this sense, 15-LOX metabolites have been shown to play both pro-and antitumorigenic actions, whereas COX metabolites are described to be tumorigenic (42) . Thus, while the expression of 15-LOX-1 inhibited intestinal epithelial cell proliferation (12, 13) , the expression of COXs is mitogenic (15) . Although several studies have implicated the pathways that synthesize 13-HODE in colorectal cancer (46) , the results obtained appear to be contradictory. Indeed, although 13(S)-HODE is described as having an antiproliferative effect in colorectal cancer (35) , a recent contradictory reference relates the racemic mixture of 13-HODE with a proliferative effect in intestinal epithelial HT-29 culture cells (14) , suggesting the hypothesis that 15-LOX-1 metabolites [13(S)-HODE and 15-HETE] as well as both 13-HODE enantiomers may have contrary effects on intestinal epithelial growth. However, few studies have examined the biological actions of 13(R)-HODE specifically, and no studies relate this metabolite to cell proliferation. The aim of the present study was to evaluate the role of 13(R)-HODE and 13(S)-HODE in intestinal epithelial cell growth and to give a new perspective within the dynamically evolving research into the role of the two enantiomers in carcinogenesis.
MATERIALS AND METHODS
Materials. DMEM, trypsin, penicillin, and streptomycin were supplied by GIBCO (Paisley, UK). Fetal bovine serum (FBS), sterile phosphate-buffered saline (PBS), 13(R)-HODE, 13(S)-HODE, 9(R)-HODE, 9(S)-HODE, U-75302, ketoprofen, SC 19220, PD98059, LY171883, bovine serum albumin (BSA), ribonuclease A from bovine pancreas, ethidium bromide, acridine orange, and propidium iodide solution were purchased from Sigma Chemical (St. Louis, MO). LY 255283 was from Tocris Bioscience (Bristol, UK). GW 9662 was purchased from Cayman Chemical (Ann Arbor, MI). AH 23838 was kindly provided by Glaxo-Wellcome (Stevenage, UK). Cell culture and cell growth assay. Caco-2 cells, derived from a colon adenocarcinoma, were provided by the American Type Culture Collection (HTB-37, Manassas, VA). The cells were routinely grown in plastic flasks at a density of 10 4 cells/cm 2 and cultured in DMEM supplemented with 4.5 g/l D-glucose, 1% (vol/vol) nonessential amino acids, 2 mM L-glutamine, 10% (vol/vol) heat-inactivated FBS, 100 U/ml penicillin, and 0.1 mg/ml streptomycin at 37°C in a modified atmosphere of 5% CO2 in air, as previously described (27) . The growth medium was replaced twice per week and the day before the experiment.
To perform the cell growth assay, cells were harvested with trypsin-EDTA and passed to 12- H]thymidine were aspirated and cells were washed, overlaid with 1% Triton X-100, and then scraped off the wells. Finally, radioactivity present in the cell fraction was measured by scintillation counting with a Packard Tri-Carb 1500 counter (Downers Grove, IL).
Fluorescence-activated cell sorting analysis-flow cytometry cell cycle analysis. Caco-2 cells were seeded in 60-mm dishes (10 4 cells/cm 2 ). After 4 days in culture, cells were incubated for 48 h with the treatments. The culture was then trypsinized, fixed with 70% ethanol, and stored at 4°C for at least 2 days. Low-molecular-weight DNA was then extracted from the cells, which were stained for 1 h at room temperature with a 20 g/ml propidium iodide solution in PBS containing 0.1% Triton X-100 and 0.2 mg/ml DNase-free RNase A. Cells were analyzed on an Epics XL flow cytometer (Coulter, Hialeah, FL). DNA was analyzed on single-fluorescence histograms by Multicycle software (Phoenix Flow Systems, San Diego, CA).
Measurement of apoptosis. Degradation of chromosomal DNA as a final result of apoptosis was evaluated with the TUNEL method. Subconfluent cell cultures (10 4 cells/cm 2 ) seeded in 60-mm dishes were incubated in medium containing 10% FBS with treatments for 48 h. Cells present in the medium and attached trypsinized cells were then collected, fixed with 4% paraformaldehyde, and permeabilized with 70% ethanol. Thereafter, 3=-OH DNA ends generated by DNA fragmentation were labeled with fluorescein-dUTP mediated by terminal deoxynucleotidyl transferase with the MEBSTAIN Apoptosis Kit (MBL, Woburn, MA) and then analyzed by an Epics XL flow cytometer (Coulter PPAR␥ ligand assay. HODE binding to peroxisome proliferatoractivated receptor-␥ (PPAR␥) was studied with a fluorescence polarization-based single-step PPAR␥ ligand screening assay (Cayman). The assay was adapted to be performed in a microcuvette with a luminescence spectrometer (AMINCO-Bowman Series 2, Spectronic Unicam, Leeds, UK). 
Measurement of cell signaling pathways activated by eicosanoids.
Cells were seeded in 60-mm plastic clusters (10 4 cells/cm 2 ), and after 4 days the cultures were incubated with the treatments (5 or 15 min). To measure the kinase activity with total cell lysates, Caco-2 cells were lysed with a denaturing cell lysis buffer containing 6 M urea, protease (2 g/ml leupeptin, 10 M pepstatin, 3 g/ml aprotinin), and phosphatase (5 mM NaF, 2 mM Na 4P2O7, 1 mM Na3VO4) inhibitors. The resulting solutions containing 80 -100 g of proteins were then added to a kinase ELISA plate, and the assay was performed according to the manufacturer's recommendations (Symansis, Auckland, New Zealand). Finally, optical density was measured at 450 nm with a TECAN absorbance reader (Tecan Austria, Salzburg, Austria). This methodology provides a qualitatively better alternative to Western blotting for simultaneous assay for activation of multiple kinases. We studied the effect of eicosanoids on the phosphorylation of AKT1 (pS473), AKT2 (pS474), ERK1/2 (pT202/Y204; pT185/Y187), GSK3␤ (pS9), p38␣ (pT180/Y182), and CREB (pS133) and on the dephosphorylation of ␤-catenin (DP S33/S37/S41). The phosphorylation of AKT, ERK, and p38 was measured after 5-min incubation with 13(R)-HODE, whereas the phosphorylation of CREB and GSK and the dephosphorylation of ␤-catenin were assayed after 15 min.
Statistics. Results are expressed as means Ϯ SE. All data were compared by one-way ANOVA and Student's t-test with SPSS software (SPSS, Chicago, IL). P Ͻ 0.05 was considered to denote significance.
RESULTS
The results showed that 13(S)-HODE (0.01-1 M) had no effect either on cell growth or on DNA synthesis in the absence of growth factors. In contrast, 13(R)-HODE (0.01-1 M) significantly increased Caco-2 growth and [
3 H]thymidine incorporation compared with cells incubated in the absence of FBS (Fig. 1) . In light of these results, a concentration of 1 M was chosen to further investigate the effects of HODE enantiomers. Interestingly, similar effects were found with 9-HODE enantiomers: 9(S)-HODE has no effect, while 9(R)-HODE had a proliferative effect without growth factors (Table 1) .
Caco-2 cell growth and DNA synthesis induced by FBS were reverted by 13(S)-HODE, showing the marked antiproliferative effect of this metabolite (Fig. 2) , while 13(R)-HODE did not show this effect. Moreover, both in the presence and in the absence of FBS, 13(S)-HODE significantly increased the percentage of apoptotic cells (Fig. 3) in Caco-2 cells, as did 9(S)-HODE (Table 1) . Thus the two HODE enantiomers have opposite effects on cell growth and apoptosis. It has been described that 13(S)-HODE binds to the nuclear PPAR␥ (7, 34) . Thus the incubation of 13(S)-HODE in the presence of a specific antagonist of PPAR␥ (GW 9662) (2) significantly reverted not only the antiproliferative effect (determined by cell growth and DNA synthesis) but also the apoptosis induced by this metabolite (Figs. 2 and 3) . In contrast, the proliferative effect of 13(R)-HODE was not inhibited by GW 9662 and, interestingly, was partially reverted by 13(S)-HODE (Fig. 2) . On the other hand, the apoptotic effect of 13(S)-HODE (Fig. 3) decreased in the presence of 13(R)-HODE, thus indicating that one HODE enantiomer reduced the effect of the other one.
Leukotriene B 4 (LTB 4 ) binds to BLT 1 and BLT 2 receptors. BLT 2 is a low-affinity receptor that was also recognized by HETEs (22, 26) . Given the similar structure of LTB 4 , HETEs, and HODEs, we tested the role of BLTs in 13(R)-HODE acting on Caco-2 cell growth. We found that the presence of BLT 1 or BLT 2 antagonists (U-75302 or LY 255283) (50) reverted the effect of 13(R)-HODE on Caco-2 proliferation and DNA synthesis (Fig. 4) . Recently, we reported that the proliferative effect of HETEs is due to COX pathway activation and PGE 2 synthesis (8) . In this sense, the proliferative effect of 13(R)-HODE was completely reverted by a COX inhibitor such as ketoprofen (40) , as well as by an EP 4 antagonist (AH 23838) (33) (Fig. 4) . The presence of an EP 1 antagonist (SC 19220) (16) also reduced both cell growth and DNA synthesis induced by 13(R)-HODE, although this effect was not statistically significant. In contrast, the antagonism of cysteinyl leukotriene receptor (LY171883) did not modify cell growth induced by 13(R)-HODE. Moreover, 13(R)-HODE (0.1-10 M) induced PGE 2 synthesis in Caco-2 cell cultures (Fig. 5 ). This synthesis was abolished by ketoprofen and, interestingly, was reduced by BLT 1 and BLT 2 antagonists.
Fatty acids and fatty acid metabolites are ligands to PPAR␥. Here we observed that 13(S)-HODE bound to PPAR␥ in a form similar to rosiglitazone, whereas 13(R)-HODE did not (Fig. 6) .
To investigate which cell signaling pathways were involved in the proliferative effect of 13(R)-HODE, we determined the phosphorylation of AKT1, AKT2, ERK1/2, p38␣, CREB, and GSK␤, as well as the dephosphorylation of ␤-catenin, in the absence of FBS and after a short incubation period (5 and 15 min) with the metabolite studied. Our results showed that 13(R)-HODE increased the phosphorylation of ERK1/2 and CREB. Moreover, CREB phosphorylation induced by 13(R)-HODE is inhibited by PD98059, an ERK inhibitor (Fig. 7) .
DISCUSSION
The aim of this study was to investigate the differential role of 13-HODE enantiomers on nondifferentiated Caco-2 cell growth. Our results indicate that 13(S)-HODE decreases cell growth and DNA synthesis, in addition to having an apoptotic effect, thus confirming the antiproliferative role of this metabolite in colonic cells. In this sense, Kamitani et al. (24) and Yoshinaga et al. (51) indicated that the induction of differen- Table 1 (23, 44, 52) .
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PPAR␥ is one of the three PPARs that make up a subfamily of the nuclear hormone receptor superfamily. 13(S)-HODE has been described as an agonist for PPAR␥ in colorectal cell lines (10, 42) . The activation of PPAR␥, a transcription factor that is expressed in epithelial cells and has been shown to inhibit cell proliferation, induces differentiation and promotes cell cycle arrest and apoptosis in colon cancer cell lines (13, 19, 30, 49) . Accordingly, our results indicate that 13(S)-HODE binds to PPAR␥ and that its antiproliferative effect is reverted in the presence of a PPAR␥ inhibitor, which reinforces the data that the binding of 13(S)-HODE to PPAR␥ possesses anti-tumorpromoting properties.
Although there are few studies of 13(R)-HODE biological effects, Shibata et al. (43) indicate that 13(R)-HODE is a PPAR␥ agonist on the atherosclerotic plaques of human carotid arteries, thus suggesting an antiproliferative role for this metabolite. In contrast, the results given here regarding Caco-2 cell growth and DNA synthesis after incubation with 13(R)-HODE suggest that this metabolite has a significant proliferative effect in the absence of any other growth factors and show, accordingly, that 13(R)-HODE effects are PPAR␥ independent. Moreover, the proliferative effect of 13(R)-HODE is confirmed by the activation of certain signaling pathways after a short incubation of this metabolite. In particular, 13(R)-HODE activates the ERK and CREB pathways. The Ras/ MAPK/ERK signaling pathway is known to be important for growth in many cell types (11) . Activation of ERK occurs through phosphorylation of threonine and tyrosine residues. There are several recent studies that indicate the importance of the Ras/ERK pathway in colorectal cancer; Ras mutations are found in 45% of colon carcinomas (47), and inhibition of the Ras/ERK pathway also promotes ABCB1 protein degradation to diminish cellular multidrug resistance in human colorectal cancer cell lines (25) . On the other hand, the activation of CREB also has a significant impact on cell growth, proliferation, and survival (39) . Thus CREB phosphorylation at its critical Ser-133 residue by ERK has been reported to increase its DNA binding activity (31) . In this report, we demonstrate that 13(R)-HODE activation of ERK leads to CREB phosphorylation at Ser-133. In line with this, Sauer et al. (41) indicated that 13-HODE activates the ERK pathway in colorectal tumors, although they did not refer to 13(S)-HODE or 13(R)-HODE. Therefore, our results suggest that the stimulation of cell proliferation by 13(R)-HODE may be mediated, at least in part, by the activation of the ERK and CREB pathways. Kim et al. (26) reported that HETEs could bind to BLT 1 and BLT 2 , LTB 4 receptors. Given the similar structure pattern of LTB 4 , HETEs, and HODEs, we also investigated the role of BLTs in Caco-2 growth induced by 13(R)-HODE. The results obtained indicate that BLT 1 and BLT 2 are involved in the proliferative effect induced by 13(R)-HODE. In addition, 13(R)-HODE activates the synthesis of PGE 2 , and this effect is reversed by COX inhibitors and, interestingly, by BLT 1 and BLT 2 antagonists. We observed that the proliferative effect of 13(R)-HODE is also inhibited by a COX inhibitor and by EP 1 and EP 4 antagonists. PGE 2 , known to be high in malignant tissue, is the predominant prostaglandin found in tumors in both animal and human models of colorectal cancer (10, 48) . Moreover, we demonstrated that PGE 2 synthesized by COX pathway is involved in the control of Caco-2 cell growth (27) . A recent study in our laboratory (8) concluded that PGE 2 induces Caco-2 cell growth and that PGE 2 production by LTB 4 and 12-HETE is also involved in the proliferation of undifferentiated Caco-2 cells. Taken together, our results suggest that the proliferative effect of 13(R)-HODE could be due, at least in part, to COX pathway activation and, subsequently, to PGE 2 synthesis.
Fewer studies on the role of 9(S)-HODE in cell proliferation were found. Hattori et al. (20) concluded that this metabolite inhibits keratinocyte proliferation. In line with this, our results also suggest an antiproliferative effect of 9(S)-HODE in nondifferentiated Caco-2 cells, whereas 9(R)-HODE presents the opposite action.
There is no information about the HODE enantiomer synthesis by cell cultures or HODE enantiomer tissue concentrations, but we observed that 13-HODE reaches a concentration around 10 nM (2.96 Ϯ 0.22 ng/ml with FBS and 0.96 Ϯ 0.02 without FBS) measured by LC-MS/MS technology (28) in Caco-2 cell culture. Shureiqi et al. (46) reported 13-HODE levels around 40 ng/g protein in colorectal mucosa, which can be equivalent to ϳ0.1-1 M, the HODE concentrations used in our experimental conditions. A future chiral separation/ quantification of HODE enantiomers will be necessary to study HODE enantiomer synthesis by intestinal epithelial cells and normal and colorectal cancer tissues.
In conclusion, we provide new evidence that 13-HODE enantiomers have contrary effects on intestinal epithelial growth (Fig. 8) . Our results show that the proliferative effect of 13(R)-HODE is PGE 2 synthesis dependent. These findings add an additional feature to the cross talk between the COX and LOX pathways, not only because of the activation by themselves of different cell signaling pathways, but also because of COX pathway activation. In fact, many studies show that in colorectal cancer the expression of 15-LOX-1 [which synthesizes 13 (S)-HODE] decreases while the expression of COX-2 [which can produce 13 (R)-HODE] increases (20, 28, 45, 48) . Thus variations in the activity of these pathways could change the balance between the two enantiomers. In colorectal cancer, this balance may be favorable to 13(R)-HODE, which could be activated PGE 2 synthesis, thus causing proliferation. Meanwhile, in differentiated epithelium the balance is pro-13(S)- HODE, by reducing cell growth and activating apoptotic processes. Moreover, in this study, the effect of one enantiomer could be reverted by the other, thus reinforcing the importance of the balance between these different pathways in cell growth homeostasis in the intestinal epithelium. Further investigations should be conducted to analyze the presence of both enantiomers along the crypt-villus axis as well as in colorectal cancer pathogenesis.
